Wednesday 17 February 2016

HFMEA Analysis of Chemotherapy in Pediatric Oncology Department 2

Introduction
Medical errors have been defined as adverse events that can impact the health and well-being of patients in the healthcare environment. The causes of medical errors can be multiple including equipment failures, poor staff training, poor communication processes, flawed healthcare structural processes, and others (Wachter, 2012). Medication errors are found to be prevalent in the pediatric inpatient setting. The potential for medication related patient injury is high in pediatric patients because they are unable to communicate regarding the side effects of improper medication administered. Pediatric patients need to be given dosage based on their weights which is an extensive process that involves calculations (Shekelle et al, 2013). In addition, the stock solutions have to be diluted in order to achieve success. A small dosage error for adult patients can have adverse impact in small children. Specifically, care must be undertaken for children that are undergoing chemotherapy for cancer treatment.  The Health Care Failure Mode and Effect Analysis (HFMEA) tool uses five steps in order to analyze the healthcare process. The use of hazard scoring matrix and flow diagrams helps to achieve the critical objectives. Additionally, the hazards can be identified based on their severity by the tool. The recommend modes of action can be identified through the use of this tool. The aim of this paper is to analyze the prescription process for chemotherapy patients in the pediatric oncology ward of a national medical center.
Setting
The research has been conducted at a medical center that comprises of a university hospital, children’s hospital, and medical facility. The medical center has approximately 9,000 employees with the children’s hospital located in a separate structure. The children’s hospital has a total of 143 beds with the oncology ward having 300 admissions in the year 2014. The age of children admitted was between 0-19 years. There is a separate pharmacy for the children’s hospital that evaluates the ordered medications. This is done in order to identify the interactions and body surface area as well as the uniformity with the chemotherapy schedule for each patient. The practitioners that use the system are provided complete information regarding the medication. The registered pediatric oncologist uses a separate system to approve the chemotherapy medications. After the approval process, the pharmacy department will send the medication for the specific patient.
Composition of HFMEA team
A number of practitioners belonging to multiple disciplines were selected on the basis of HFMEA guidelines. There were nine members while two advisors were included in the multidisciplinary team. Additionally, a parent was involved because her child has been receiving chemotherapy treatment for the past one year. The team was led by the hospital’s patient safety coordinator. The other members were from the pharmacy, pediatric oncology department, nursing department, and medical department.




Process Description
Prescription
This process involves the prescription of medications for the child patient that is admitted in the hospital. The treatment schedule in the chart is selected with proper dose calculation and prescription entry into the system by the resident in the pediatric oncology department. The prescription is printed out with the supportive care orders documented by the resident. The prescription print out is sent to the nursing department. An oncologist must authorize the prescription. After that, the prescription print out is processed and checked by the nurses. 
Processing Pharmacy
The prescription is matched with the treatment schedule for the patient. The preparation protocol mode is initiated which is evaluated by the pharmacist. The authorization from the oncologist is processed while the department strives to ensure that the medication is prepared. The medication is properly labeled and presented in a tube so that it can be checked by the pharmacist before being finally handed over to the nursing department.
Administration
The administration department collects the medication from the pharmacy department and stores it in the refrigerator. The prescription is checked with the print out and handed over to the nurses. The nurses connect the medication tube to the patient while striving to adjust the medication pump in the patient. The pump is started so that the medication can be administered to the patient. When this process is finished than the pump is flushed out while the nurses mark that the medication has been administered to the patient.
Failure Modes
One of the primary hazards that have been identified is related to the chemotherapy treatment schedule that is depicted through charts. This occurs because of the fact that pediatric oncologist did not provide timely updates on the chart.  Another hazard is related to improper dosage by the resident in the pediatric oncology department. The possible causes for this hazard are the increased number of hours for residents. Alternatively, the use of pagers in the department can also distract the resident when they are preparing the dosage for chemotherapy. Other hazards identified in the analysis have been the failure of the nursing staff and pharmacy department to check the changes in prescription of medication that is used for chemotherapy for young patients. The causes can be failure of the department to check out the prescription as well as the resident failing to inform the nurses. Another hazard identified has been old dose delivered by the pharmacy once authorized medication has been changed for the patients. Finally, another hazard that was identified was extravasation of peripheral venous access which is a rare process. This means that residents or nurses are unaware of the risks of peripheral venous access.
Recommended Actions
A standardized chemotherapy chart scheduled has been recommended because the standard procedure for changes can help to implement high levels of uniformity and consistency with respect to provision of care to the oncology patients (Keers et al, 2013). Moreover, standardized processes help to ensure that practitioners can work in an integrated manner in order to respond to problems. The information can be accessed which helps to achieve efficiency and effectiveness. Another important recommendation is to reduce the work hours that can play an instrumental role in mitigating medical errors. New doctors that join a team are at higher risks of making prescription errors.
The recommendation is therefore to place minimum number of residents in the pediatric oncology ward. The use of pagers was prohibited because it can cause distraction in the ward. Additionally, the residents are provided with maximum concentration for prescribing chemotherapy in a separate room in order to reduce the chances of errors.  Another recommendation is to implement an electronically controlled administration system that would help to provide sound information to the healthcare workforce. This is because the changes in prescriptions that have been authorized go disregarded by the nursing staff (Keers et al, 2013).
 The pharmacy department would be notified by telephone about changes in medications. This is because the pharmacy department might deliver the incorrect chemotherapy once change has been implemented in an authorized order. This is done in order to prevent medication errors so that patient safety can be promoted in an efficient and effective manner. Vincristine should be a administered by a peripheral intravenous access by a trained pediatric oncologist in order to ensure efficiency. Nurses and residents do not have knowledge about the risk of extravasation of the heart when peripheral intravenous access is used for the purposes of treating the patients.
Discussion
Prescription errors are a critical issue in the healthcare environment as they can prolong the hospitalization stays for patients. In other cases, prescription errors might be fatal for the patient. Specifically, the prescription errors can increase costs for the patient as well as the hospital. HFMEA is an appropriate tool for diagnosing problems and hazards that are encountered in the healthcare environment (Ghaferi & Dimick, 2015).


In addition, it can be used for analyzing the prescription process in a pediatric oncology ward. The case discusses the administration of chemotherapy which is vincristine. The analysis suggests that there are multiple hazards that can cause medication errors and jeopardize patient safety. Prescription errors can be multifaceted in nature because of the analysis that has been undertaken in this paper. The analysis using the HFMEA tool is important since it helps to identify the multiple hazards and the possible solutions to resolve them. It provides accurate and reliable information to the management so that they can make critical decisions that can lead to high levels of efficiency and effectiveness. The recommendations target the specific failure modes by using proactive and dynamic strategies in order mitigate the chances of errors related to prescription in the oncology ward (Duwe et al, 2005). The HFMEA was conducted through a multidisciplinary team which helps to achieve the critical objectives of analyzing hazards in the healthcare environment. In addition, a parent was part of the team because they can provide valuable feedback about the entire process. Specifically, the success of HFMEA occurs when the hospital management is involved in the entire process. The analysis suggests that administrative and technological processes need to be implemented in order to reduce prescription errors. Moreover, the staff must be appropriately trained so that they can work in providing continuity of care for the patients. The staff must be aware about the implications of prescription errors. Communication processes need to be strengthened so that prescription errors can be mitigated. The flow and exchange of information should be done in a consistent manner in order to reduce the chances of errors. Technology can be used to create quality and efficient healthcare services in the oncology department. It can be used for storing patient information and medication information which is vital for the success of the medical center (Shebl et al, 2012).

Conclusion
HFMEA is an appropriate tool that has been used to study the medication errors that can occur in the pediatric oncology ward of a national medical center. Medication errors need to be combated through the presence of a patient safety culture. The staff must work in a coordinated manner with each other so that they are able to successfully develop proactive and dynamic strategies in responding to problems occurring in the environment. Proper research and analysis is important for the healthcare team so that they can identify the source of medication errors. The HFMEA tool used for the oncology department found that there are several sources of medication errors in the hospital environment. A proactive and integrated strategy is needed in order to combat the problem. This can be done through the use of clear and precise goals. Another recommendation is to implement an electronically controlled administration system that would help to provide sound information to the healthcare workforce. This is because the changes in prescriptions that have been authorized go disregarded by the nursing staff.  The pharmacy department would be notified by telephone about changes in medications. This is because the pharmacy department might deliver the incorrect chemotherapy once change has been implemented in an authorized order. This is done in order to prevent medication errors so that patient safety can be promoted in an efficient and effective manner.












References

Duwe B, Fuchs B D, HansenFlaschen J. (2005). Failure mode and effects analysis application to critical care medicine. Crit Care Clin 2121–30, vii.3

Ghaferi, A. A., & Dimick, J. B. (2015). Understanding Failure to Rescue and Improving Safety Culture. Annals of surgery, 261(5), 839-840.

Keers, R. N., Williams, S. D., Cooke, J., & Ashcroft, D. M. (2013). Prevalence and nature of medication administration errors in health care settings: a systematic review of direct observational evidence. Annals of Pharmacotherapy, 47(2), 237-256.

Keers, R. N., Williams, S. D., Cooke, J., & Ashcroft, D. M. (2013). Causes of medication administration errors in hospitals: a systematic review of quantitative and qualitative evidence. Drug safety, 36(11), 1045-1067.

Shebl, N. A., Franklin, B. D., & Barber, N. (2012). Failure mode and effects analysis outputs: are they valid?. BMC health services research, 12(1), 150.

Shekelle, P. G., Pronovost, P. J., Wachter, R. M., McDonald, K. M., Schoelles, K., Dy, S. M., ... & Bates, D. W. (2013). The top patient safety strategies that can be encouraged for adoption now. Annals of Internal Medicine, 158(5_Part_2), 365-368.

Wachter, R. M. (2012). Understanding patient safety. McGraw Hill Medical.


0 comments:

Post a Comment